Levothyroxine sodium
- Product NDC
- 50090-7527
- 11-digit product format
- 500907527
- Labeler code
- 50090
- Product ID
- 50090-7527_e3043b69-562e-4891-82d8-a52fc7768cc7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Levothyroxine sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA207588
- Marketing category
- ANDA
- Marketing start
- 2022-09-21
- Substance
- LEVOTHYROXINE SODIUM
- Active strength
- 112 ug/1
- Pharmacologic classes
- Thyroxine [CS], l-Thyroxine [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Levothyroxine sodium
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LEVOTHYROXINE SODIUM | 112 ug/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 9J765S329G |
| Rxcui | 966248 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-7527-0 | Levothyroxine sodium | 90 in 1 BOTTLE | TABLET | 90 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-7527 | LEVOTHYROXINE SODIUM TABLET [A-S MEDICATION SOLUTIONS] | 2 | Current NDC, 1 package rows | 20250418_65b266af-72a5-4409-ab55-bd14341135aa.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 50090-7527-0 | 50090752700 | 90 TABLET in 1 BOTTLE (50090-7527-0) | 90 tablet | 2025-04-03 | No | No | Historical |